1.Perinatal risk factors for hemodynamically significant patent ductus arteriosus in very low birth weight infants
Jie Hee JUE ; So Young SHIN ; Jae Hyun PARK ; Chun Soo KIM ; Hee Joung CHOI
Clinical and Experimental Pediatrics 2026;69(4):313-321
Background:
Multiple perinatal factors influence hemodynamically significant patent ductus arteriosus (HS PDA) in preterm infants.Purpose: This study aimed to identify the risk factors associated with HS PDA in very low birth weight infants (VLBWIs) and determine the predictors of surgical ligation.
Methods:
This retrospective study included VLBWIs born at 23–32 weeks’ gestation whose HS PDA properties could be identified using echocardiography. The infants were stratified into 2 groups based on gestational age (23–27 and 28–32 weeks).
Results:
Among the 496 included VLBWIs, 171 had no PDA, 90 had non-HS PDA, and 235 had HS PDA. In infants born at 23–27 weeks’ gestation, risk factors for HS PDA included low birth weight, the absence of histological chorioamnionitis, and premature rupture of membranes. For VLBWIs born at 28–32 weeks’ gestation, HS PDA was associated with lower birth weight, frequent surfactant treatment, and maternal hypertension. Within the HS PDA group, infants with a lower birth weight or who received incomplete antenatal steroid administration had an increased likelihood of requiring surgical ligation, whereas those with a small-for-gestational-age status had a decreased need for surgical ligation.
Conclusion
Recognizing these risk factors can aid the development of targeted treatment strategies for HS PDA in VLBWIs, enabling early ligation and potentially reducing the need for surgical management.
2.Factors influencing the use of implantable cardioverter-defibrillators for primary prevention in ischemic cardiomyopathy according to implantation volume: a prospective multicenter registry
Tae-Hoon KIM ; Hee Tae YU ; Il-Young OH ; Eue-Keun CHOI ; Jung-Hoon SUNG ; Young Soo LEE ; Jong-Youn KIM ; Yong-Soo BAEK ; Junbeom PARK ; Boyoung JOUNG ;
International Journal of Arrhythmia 2026;27(1):e8-
Background and Objectives:
Primary prevention (PP) implantable cardioverter-defibrillator (ICD) therapy for ischemic cardiomyopathy (ICM) is underused in Asian countries, including South Korea. Both clinical and hospital factors may influence appropriate ICD use. We evaluated whether determinants of PP ICD implantation differ by hospital implantation volume.
Methods:
In this prospective, multicenter observational registry (blinded for review), patients eligible for PP ICD were enrolled. Factors associated with ICD implantation—clinical characteristics and hospital-level systems—were examined across 4 large-volume hospitals (≥ 15 implants during the study) and 12 small-volume hospitals (< 15). Multivariable logistic regression identified independent predictors.
Results:
Among 3,083 ICM patients (2,403 men; median age 70 years), PP ICD implantation rates were 10.8% in large-volume and 5.7% in small-volume hospitals. Across groups, male sex and chronic kidney disease independently predicted ICD implantation. Regarding hospital factors, non-monetary incentives for referral were the sole independent predictor in large-volume centers (odds ratio [OR], 3.55; 95% confidence interval [CI], 2.07–6.10;P < 0.001). In small-volume centers, heart failure conferences (OR, 12.73; 95% CI, 1.72–94.37;P = 0.013), structured education systems (OR, 11.72; 95% CI, 2.45–56.12; P = 0.02), and pacemaker clinics (OR, 11.4; 95% CI, 2.24–58.39; P = 0.003) were independently associated with implantation.
Conclusions
Clinical predictors of PP ICD use were consistent across hospital volumes, but hospital-level determinants differed. Referral incentives characterized large-volume centers, whereas conferences, education systems, and pacemaker clinics were key in smallvolume centers. Tailored institutional strategies by hospital volume may help close the PP ICD underuse gap and improve evidence-based implementation.
3.A Prospective, Multicenter Study on the Clinical Effectiveness and Safety of Abiraterone Plus Prednisone in Metastatic Hormone-Sensitive Prostate Cancer in Korea: Real-World Data Analysis
Hyomyoung LEE ; Seung-hwan JEONG ; Sangeun YEON ; Youngdoe KIM ; Jaeyoung JOUNG ; Hanjong AHN ; Seongsoo JEON ; Hakmin LEE ; Sangchul LEE ; Choung-Soo KIM ; Cheol KWAK
Journal of Urologic Oncology 2025;23(2):119-125
Purpose:
This postmarketing surveillance (PMS) study aimed to evaluate real-world data on the effectiveness and safety of abiraterone acetate plus prednisone (AAP) in patients with metastatic hormone-sensitive prostate cancer (mHSPC).
Materials and Methods:
This prospective, multicenter observational study was conducted at 27 centers in South Korea between June 2018 and April 2021. Among 117 enrolled patients, 108 were included in the final analysis. Median follow-up period was 40.4 weeks (interquartile range, 22.8–49.2 weeks). Patients aged ≥18 years with mHSPC treated with AAP were included. Effectiveness endpoints included radiographic progression-free survival (rPFS), time to prostate-specific antigen (PSA) progression (TTPP), and PSA response (≥50%, ≥90% reduction). Adverse events (AEs) were assessed and graded based on severity.
Results:
A total of 108 patients were included in the analysis. Radiographic and PSA progression were observed in 13 (12.0%) and 26 patients (24.1 %), respectively. In the Kaplan-Meier analysis, the median rPFS and TTPP were not reached. The PSA response rates were 85.2% (≥50% reduction) and 75.9% (≥90% reduction) during the study period. AEs were reported in 31 patients (28.7%), with grade 3 or 4 AEs reported in 6 patients (5.6%). The most frequently observed AE was elevated aspartate aminotransferase level (5.6%).
Conclusion
This PMS study found that AAP is effective and well-tolerated in the real-world management of mHSPC.
4.Exploring the potential utility of a single-item perceived diet quality measure
Soo Hyun KIM ; Hyojee JOUNG ; Seul Ki CHOI
Nutrition Research and Practice 2024;18(6):845-856
BACKGROUND/OBJECTIVES:
Perceived diet quality (PDQ) has been suggested as an easy-touse dietary assessment tool. However, its practicality and efficiency are still questionable.This study aimed to gauge the utility of PDQ as an alternative dietary assessment tool among Korean adults by examining PDQ and its associated factors.
SUBJECTS/METHODS:
An online survey was conducted on 514 Korean adults aged 19 to 64 years in October 2022. PDQ was assessed using a 5-point Likert scale, and participants were categorized into healthy, fair, or unhealthy PDQ groups. The participants were asked about the perceived importance of nutrients and food groups for health and the extent to which they considered these factors in their usual diets using a 5-point Likert scale. A multivariate linear regression model was used to identify the factors associated with PDQ.
RESULTS:
About 26.7% of participants rated their diets as healthy, while 63.2% rated them as fair and 10.1% rated them as unhealthy. Participants with a healthy PDQ rated perceived importance and consideration of nutrients and food groups higher than the fair or unhealthy PDQ groups. A healthier PDQ was associated with the male gender, an older age, being normal or underweight, having better subjective health, lower use of alcohol, being physically active, having a high interest in healthy diets, and a higher perception of the importance of nutrients and food groups for health.
CONCLUSION
The PDQ could serve as a simple and rapid screening tool for identifying individuals at risk of poor diets.
5.Analysis of the characteristics of dietary information acquisition and perceptions on the Dietary Reference Intakes for Koreans among Korean adults
Journal of Nutrition and Health 2024;57(6):653-666
Purpose:
This study examined the characteristics of dietary information acquisition and perceptions on the Dietary Reference Intakes for Koreans (KDRIs) and related guidelines, the Food Balance Wheel and Target Pattern, focusing on the differences according to gender and experience of acquiring dietary information.
Methods:
Five hundred and fourteen Korean adults aged 19–64 years participated in an online survey and were categorized according to gender and whether they had experience acquiring dietary information. The differences in the general characteristics, dietary behaviors, and perceptions of KDRIs and related guidelines were analyzed using χ 2 tests.
Results:
Among the participants, 68.1% reported having experience acquiring dietary information, with a higher proportion of women (76.2%) than men (60.1%). Women with such experiences were older, more physically active, experienced in diet management, and showed greater interest in healthy eating and dietary information (p < 0.05 for all). Men with experience also had more diet management experience and showed higher interest in healthy eating and dietary information (p < 0.05 for all). Dietary information was acquired primarily from the Internet, followed by mass media, online video platforms, and social media. The major inconvenience in using dietary information was the lack of tailored content and insufficient detail. The awareness of KDRIs and related guidelines was higher among those with experience in acquiring dietary information. On the other hand, understanding and applicability of these guidelines showed no significant differences across groups.
Conclusion
This study found that the proportion of individuals acquiring nutrition information varied according to gender and lifestyle behaviors. Most participants acquired information primarily through the Internet. The awareness of KDRIs and related guidelines was higher among those with experience in acquiring dietary information. These findings suggest that the strategies for providing nutrition information should consider the characteristics of Korean adults to improve effectiveness.
6.Exploring the potential utility of a single-item perceived diet quality measure
Soo Hyun KIM ; Hyojee JOUNG ; Seul Ki CHOI
Nutrition Research and Practice 2024;18(6):845-856
BACKGROUND/OBJECTIVES:
Perceived diet quality (PDQ) has been suggested as an easy-touse dietary assessment tool. However, its practicality and efficiency are still questionable.This study aimed to gauge the utility of PDQ as an alternative dietary assessment tool among Korean adults by examining PDQ and its associated factors.
SUBJECTS/METHODS:
An online survey was conducted on 514 Korean adults aged 19 to 64 years in October 2022. PDQ was assessed using a 5-point Likert scale, and participants were categorized into healthy, fair, or unhealthy PDQ groups. The participants were asked about the perceived importance of nutrients and food groups for health and the extent to which they considered these factors in their usual diets using a 5-point Likert scale. A multivariate linear regression model was used to identify the factors associated with PDQ.
RESULTS:
About 26.7% of participants rated their diets as healthy, while 63.2% rated them as fair and 10.1% rated them as unhealthy. Participants with a healthy PDQ rated perceived importance and consideration of nutrients and food groups higher than the fair or unhealthy PDQ groups. A healthier PDQ was associated with the male gender, an older age, being normal or underweight, having better subjective health, lower use of alcohol, being physically active, having a high interest in healthy diets, and a higher perception of the importance of nutrients and food groups for health.
CONCLUSION
The PDQ could serve as a simple and rapid screening tool for identifying individuals at risk of poor diets.
9.Late-Onset Bilateral Nevus Comedonicus of the Eyelids:A Rare Presentation
Hyun-Min SEO ; Seon Young SONG ; Se Uk OH ; Ji Hun PARK ; Joung Soo KIM
Korean Journal of Dermatology 2024;62(4):238-241
Nevus comedonicus (NC, acneiform nevus) is a rare variant of adnexal hamartoma, which is clinically characterized as confluent clusters of dilated follicular orifices resembling comedones. NC usually occurs unilaterally along the line of Blaschko and presents at birth or develops during childhood. A 66-year-old man presented with a 6-month history of multiple skin-colored to brownish papules resembling comedones on both the upper and lower eyelids.The patient did not complain of ophthalmologic or neurologic symptoms. Skin punch biopsy revealed dilated follicular openings filled with eosinophilic keratinous material and lymphocytic infiltration. Based on clinical and histopathologic findings, a diagnosis of late-onset bilateral NC of the eyelids was reached.
10.Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy+Abiraterone/Prednisone and Androgen Deprivation Therapy+Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer
Dong Jin PARK ; Tae Gyun KWON ; Jae Young PARK ; Jae Young JOUNG ; Hong Koo HA ; Seong Soo JEON ; Sung-Hoo HONG ; Sungchan PARK ; Seung Hwan LEE ; Jin Seon CHO ; Sung-Woo PARK ; Se Yun KWON ; Jung Ki JO ; Hong Seok PARK ; Sang-Cheol LEE ; Dong Deuk KWON ; Sun Il KIM ; Sang Hyun PARK ; Soodong KIM ; Chang Wook JEONG ; Cheol KWAK ; Seock Hwan CHOI ;
The World Journal of Men's Health 2024;42(3):620-629
Purpose:
This study aimed to compare the short-term outcomes and safety profiles of androgen-deprivation therapy (ADT)+abiraterone/prednisone with those of ADT+docetaxel in patients with de novo metastatic hormone-sensitive prostate cancer (mHSPC).
Materials and Methods:
A web-based database system was established to collect prospective cohort data for patients with mHSPC in Korea. From May 2019 to November 2022, 928 patients with mHSPC from 15 institutions were enrolled. Among these patients, data from 122 patients who received ADT+abiraterone/prednisone or ADT+docetaxel as the primary systemic treatment for mHSPC were collected. The patients were divided into two groups: ADT+abiraterone/prednisone group (n=102) and ADT+docetaxel group (n=20). We compared the demographic characteristics, medical histories, baseline cancer status, initial laboratory tests, metastatic burden, oncological outcomes for mHSPC, progression after mHSPC treatment, adverse effects, follow-up, and survival data between the two groups.
Results:
No significant differences in the demographic characteristics, medical histories, metastatic burden, and baseline cancer status were observed between the two groups. The ADT+abiraterone/prednisone group had a lower prostate-specific antigen (PSA) progression rate (7.8% vs. 30.0%; p=0.011) and lower systemic treatment discontinuation rate (22.5% vs. 45.0%; p=0.037). No significant differences in adverse effects, oncological outcomes, and total follow-up period were observed between the two groups.
Conclusions
ADT+abiraterone/prednisone had lower PSA progression and systemic treatment discontinuation rates than ADT+docetaxel. In conclusion, further studies involving larger, double-blinded randomized trials with extended follow-up periods are necessary.

Result Analysis
Print
Save
E-mail